Health Canada approves Pfizer's updated COVID-19 vaccine, manufacturer says [Globe and Mail, The (Toronto, Canada)]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Globe and Mail, The
Log in or create a free account to listen to this article. Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The Pfizer-BioNTech mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant. Health Canada recently asked provinces and territories to get rid of their older COVID-19 vaccines to ensure the most current vaccine will be used during this fall's respiratory virus season. Comirnaty is the third updated COVID-19 vaccine approved by Health Canada for this season, following its authorization of Moderna's Spikevax mRNA vaccine and Novavax's protein-based vaccine, Nuvaxovid, last week. Both the Pfizer and Moderna vaccines are approved for adults and for children six months of age and older. Novavax is approved for adults and for children 12 years and older. Sign up for our re
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Free COVID-19 tests are now available. Here's how you can get them. [USA TODAY]USA TODAY
- COVID cases are on a downward trend. How long will this last? [USA TODAY]USA TODAY
- Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & DevelopmentPR Newswire
- Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]Yahoo! Finance
- Florida's New Guidance For COVID-19 Vaccines Stokes Fears Instead Of Saving Lives [Forbes]Forbes
NVAX
Earnings
- 8/8/24 - Miss
NVAX
Sec Filings
- 9/18/24 - Form 144
- 8/21/24 - Form 4
- 8/20/24 - Form 4
- NVAX's page on the SEC website